Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.006 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.088 | 0.04 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |